Paperpal Prime Logo

The Lancet Child and Adolescent Health : Impact Factor & More

eISSN: 2352-4642pISSN: 2352-4642

Key Metrics

CiteScore
21.7
Scite Index
0.86 5-Year SI
SNIP
6.5
Recommended pre-submission checks
Powered by Paperpal by Editage

The Lancet Child and Adolescent Health Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher ELSEVIER SCI LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2017
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in The Lancet Child and Adolescent Health ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in The Lancet Child and Adolescent Health

Efficacy and safety of risdiplam in patients with type 1 spinal muscular atrophy: a 3-year open-label extension of the two-part, phase 2 FIREFISH trial.
  • 1 Sep 2026
  • The Lancet. Child & adolescent health
Orphanhood and caregiver loss after Venezuela's earthquake doublet: an overlooked child health crisis.
  • 1 Sep 2026
  • The Lancet. Child & adolescent health
A national programme of bivalent prefusion F vaccination in pregnancy and protection against respiratory syncytial virus hospitalisation in infants until age 6 months in the UK: a multicentre, prospective, test-negative, case-control study.
  • 1 Sep 2026
  • The Lancet. Child & adolescent health
Associations between childhood somatic conditions and psychiatric diagnoses in autistic young adults: a retrospective, population-based cohort study in Sweden.
  • 1 Sep 2026
  • The Lancet. Child & adolescent health
A decade of disease-modifying therapies for spinal muscular atrophy.
  • 1 Sep 2026
  • The Lancet. Child & adolescent health
From PCOS to PMOS: inclusion of the adolescent voice in setting clinical and research priorities.
  • 1 Sep 2026
  • The Lancet. Child & adolescent health
Efficacy and safety of risdiplam in patients with type 1 spinal muscular atrophy: a 3-year open-label extension of the two-part, phase 2 FIREFISH trial.
  • 1 Sep 2026
  • The Lancet. Child & adolescent health
Orphanhood and caregiver loss after Venezuela's earthquake doublet: an overlooked child health crisis.
  • 1 Sep 2026
  • The Lancet. Child & adolescent health
A national programme of bivalent prefusion F vaccination in pregnancy and protection against respiratory syncytial virus hospitalisation in infants until age 6 months in the UK: a multicentre, prospective, test-negative, case-control study.
  • 1 Sep 2026
  • The Lancet. Child & adolescent health
Associations between childhood somatic conditions and psychiatric diagnoses in autistic young adults: a retrospective, population-based cohort study in Sweden.
  • 1 Sep 2026
  • The Lancet. Child & adolescent health
A decade of disease-modifying therapies for spinal muscular atrophy.
  • 1 Sep 2026
  • The Lancet. Child & adolescent health
From PCOS to PMOS: inclusion of the adolescent voice in setting clinical and research priorities.
  • 1 Sep 2026
  • The Lancet. Child & adolescent health

FAQs on The Lancet Child and Adolescent Health